Patents by Inventor Benjamin J. Feldman

Benjamin J. Feldman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190274597
    Abstract: Method and system for determining real time analyte concentration including an analyte sensor having a portion in fluid contact with an interstitial fluid under a skin layer, an on-body electronics including a housing coupled to the analyte sensor and configured for positioning on the skin layer, the on-body electronics housing including a plurality of electrical contacts , on the housing; and a data analysis unit having a data analysis unit housing and a plurality of probes , on the housing. Each of the probes configured to electrically couple to a respective electrical contact when the data analysis unit is positioned in physical contact with the on-body electronics. The one or more signals on the probes correspond to one or more of a substantially real time monitored analyte concentration level (MACL), MACL over a predetermined time period, or a rate of change of the MACL, or combinations thereof, are provided.
    Type: Application
    Filed: May 14, 2019
    Publication date: September 12, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Benjamin J. Feldman, Zenghe Liu, Hyun Cho, Benjamin M. Rush
  • Patent number: 10392647
    Abstract: Enzyme compositions including lactate responsive enzyme and stabilizing agent, including electrodes, sensors, and systems having the same. The stabilizing agent stabilizes the lactate responsive enzyme in a manner sufficient to increase sensitivity to lactate, such as for use in in vivo detection of lactate. In some compositions the lactate responsive enzyme is lactate oxidase and the sensor includes a heterocycle-containing polymer and a crosslinker.
    Type: Grant
    Filed: January 26, 2018
    Date of Patent: August 27, 2019
    Assignee: Abbot Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman, Kuan-chou Chen
  • Publication number: 20190150809
    Abstract: An analyte sensor including an antiglycolytic agent or a precursor thereof and a chelating agent that stabilizes the antiglycolytic agent positioned proximate to the working electrode of the sensor. Also provided are systems and methods of using the electrochemical analyte sensors in analyte monitoring.
    Type: Application
    Filed: January 21, 2019
    Publication date: May 23, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Zenghe Liu, Hyun Cho, Benjamin J. Feldman
  • Patent number: 10285632
    Abstract: Method and system for determining real time analyte concentration including an analyte sensor having a portion in fluid contact with an interstitial fluid under a skin layer, an on-body electronics including a housing coupled to the analyte sensor and configured for positioning on the skin layer, the on-body electronics housing including a plurality of electrical contacts, on the housing; and a data analysis unit having a data analysis unit housing and a plurality of probes, on the housing. Each of the probes configured to electrically couple to a respective electrical contact when the data analysis unit is positioned in physical contact with the on-body electronics. The one or more signals on the probes correspond to one or more of a substantially real time monitored analyte concentration level (MACL), MACL over a predetermined time period, or a rate of change of the MACL, or combinations thereof, are provided.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: May 14, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Benjamin J. Feldman, Zenghe Liu, Hyun Cho, Benjamin M. Rush
  • Patent number: 10219728
    Abstract: An analyte sensor including an antiglycolytic agent or a precursor thereof and a chelating agent that stabilizes the antiglycolytic agent positioned proximate to the working electrode of the sensor. Also provided are systems and methods of using the electrochemical analyte sensors in analyte monitoring.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: March 5, 2019
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Zenghe Liu, Hyun Cho, Benjamin J. Feldman
  • Publication number: 20190024130
    Abstract: Embodiments of the present disclosure relate to NADP-dependent oxidoreductase compositions, and electrodes, sensors and systems that include the same. Also provided are methods for making the compositions and for detecting and/or measuring analytes with NADP-dependent oxidoreductase compositions.
    Type: Application
    Filed: March 2, 2017
    Publication date: January 24, 2019
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman
  • Publication number: 20180339104
    Abstract: The present disclosure provides an orientation-nonspecific sensor port for use in analyte meters designed to detect and quantify analyte levels in a fluid sample along with methods of using the same. The present disclosure also provides compositions and methods for facilitating the correct insertion of a sensor into a corresponding analyte meter.
    Type: Application
    Filed: July 23, 2018
    Publication date: November 29, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Yi Wang, Benjamin J. Feldman, Benjamin M. Rush
  • Publication number: 20180296139
    Abstract: Generally, embodiments of the invention relate to self-powered analyte determining devices (e.g., electrochemical analyte monitoring systems) that include a working electrode, a counter electrode, and an optional resistance value, where the working electrode includes analyte sensing components and the self-powered analyte determining device spontaneously passes a current directly proportional to analyte concentration in the absence of an external power source. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Application
    Filed: June 22, 2018
    Publication date: October 18, 2018
    Inventors: Benjamin J. Feldman, Zenghe Liu, Tianmei Ouyang
  • Publication number: 20180256103
    Abstract: Systems, devices and methods are provided for the monitoring and management of an individual's wellness and nutrition using analyte data from an in vivo analyte sensor. Generally, a sensor control device is provided for wear on the body. The sensor control device can include an in vivo analyte sensor for measuring an analyte level in a bodily fluid, an accelerometer for measuring the physical activity level of the subject, as well as communications circuitry for wirelessly transmitting data to a reader device. Furthermore, disclosed herein are embodiments of various graphical user interfaces for displaying analyte metrics on a reader device, comparing the analyte response of various foods and/or meals, modifying daily nutrient recommendations based on analyte metrics and physical activity level measurements, and other features described herein. Additionally, the embodiments disclosed herein can be used to monitor various types of analytes.
    Type: Application
    Filed: February 27, 2018
    Publication date: September 13, 2018
    Inventors: Jean-Pierre Cole, Benjamin J. Feldman, Udo Hoss, Namvar Kiaie, Frederic T. Arbogast
  • Publication number: 20180256083
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a membrane structure with an analyte permeability that is substantially temperature independent. The devices also include a sensing layer disposed on a working electrode of in vivo analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Application
    Filed: May 14, 2018
    Publication date: September 13, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Benjamin J. Feldman, Tianmei Ouyang
  • Publication number: 20180252660
    Abstract: Provided are sensors for determining the concentration of an analyte in a sample fluid. In certain embodiments, the sensors include conductive particles and exhibit improved uniformity of distribution of one or more sensing chemistry components, increased effective working electrode surface area, and/or reduced entry of interfering components into a sample chamber of the sensor. Methods of using and manufacturing the sensors are also provided.
    Type: Application
    Filed: April 27, 2018
    Publication date: September 6, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Zenghe Liu, Tianmei Ouyang, Suyue Qian
  • Patent number: 10058653
    Abstract: The present disclosure provides an orientation-nonspecific sensor port for use in analyte meters designed to detect and quantify analyte levels in a fluid sample along with methods of using the same. The present disclosure also provides compositions and methods for facilitating the correct insertion of a sensor into a corresponding analyte meter.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: August 28, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Yi Wang, Benjamin J. Feldman, Benjamin M. Rush
  • Patent number: 10022076
    Abstract: Embodiments of the present disclosure relate to analyte determining methods and devices (e.g., electrochemical analyte monitoring systems) that have a membrane structure with an analyte permeability that is substantially temperature independent. The devices also include a sensing layer disposed on a working electrode of in vivo analyte sensors, e.g., continuous and/or automatic in vivo monitoring using analyte sensors and/or test strips. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Grant
    Filed: May 26, 2017
    Date of Patent: July 17, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Udo Hoss, Benjamin J. Feldman, Tianmei Ouyang
  • Publication number: 20180192932
    Abstract: Analyte sensor assemblies comprising: an electrochemical sensor for determining a concentration of an analyte and an electrochemical sensor control unit. The electrochemical sensor comprising a working electrode having a sensing layer and a non-crosslinked cubic phase lyotropic liquid crystal membrane disposed over the sensing layer, the sensing layer comprising an analyte-responsive enzyme, and a counter electrode in communication with the working electrode. And the electrochemical sensor control unit comprising a housing adapted for placement on or implantation in a patient's skin, and sensor control unit electronics. Wherein a measured current from an applied potential between the working electrode and the counter electrode correlates to a concentration of an analyte.
    Type: Application
    Filed: January 18, 2018
    Publication date: July 12, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Adam Heller, Pawel Rowinski, Benjamin J. Feldman
  • Patent number: 10004441
    Abstract: Generally, embodiments of the invention relate to self-powered analyte determining devices (e.g., electrochemical analyte monitoring systems) that include a working electrode, a counter electrode, and an optional resistance value, where the working electrode includes analyte sensing components and the self-powered analyte determining device spontaneously passes a current directly proportional to analyte concentration in the absence of an external power source. Also provided are systems and methods of using the, for example electrochemical, analyte sensors in analyte monitoring.
    Type: Grant
    Filed: November 14, 2016
    Date of Patent: June 26, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Benjamin J. Feldman, Zenghe Liu, Tianmei Ouyang
  • Patent number: 10002233
    Abstract: Methods and apparatus for providing data processing and control for use in a medical communication system are provided.
    Type: Grant
    Filed: May 14, 2008
    Date of Patent: June 19, 2018
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary Hayter, Lei He, Mark K. Sloan, Benjamin J. Feldman
  • Publication number: 20180153449
    Abstract: Silver/Silver Chloride (Ag/AgCl) based reference electrodes, their use, and manufacture, having extended lifetimes that are suitable for use in long term amperometric sensors. Electrochemical sensors, including implantable biosensors such as glucose sensors, equipped with the reference electrodes described herein demonstrate considerable stability and extended lifetime in a variety of conditions.
    Type: Application
    Filed: January 10, 2018
    Publication date: June 7, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Zenghe Liu, Benjamin J. Feldman, Hyun Cho, Udo Hoss
  • Publication number: 20180148758
    Abstract: Enzyme compositions including lactate responsive enzyme and stabilizing agent, including electrodes, sensors, and systems having the same. The stabilizing agent stabilizes the lactate responsive enzyme in a manner sufficient to increase sensitivity to lactate, such as for use in in vivo detection of lactate. In some compositions the lactate responsive enzyme is lactate oxidase and the sensor includes a heterocycle-containing polymer and a crosslinker.
    Type: Application
    Filed: January 26, 2018
    Publication date: May 31, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Benjamin J. Feldman, Kuan-chou Chen
  • Patent number: 9983161
    Abstract: Provided are sensors for determining the concentration of an analyte in a sample fluid. In certain embodiments, the sensors include conductive particles and exhibit improved uniformity of distribution of one or more sensing chemistry components, increased effective working electrode surface area, and/or reduced entry of interfering components into a sample chamber of the sensor. Methods of using and manufacturing the sensors are also provided.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: May 29, 2018
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Zenghe Liu, Tianmei Ouyang, Suyue Qian
  • Publication number: 20180094290
    Abstract: Embodiments of the invention include analyte-responsive compositions and electrochemical analyte sensors having a sensing layer that includes an analyte-responsive enzyme and a cationic polymer. Also provided are systems and methods of making the sensors and using the electrochemical analyte sensors in analyte monitoring.
    Type: Application
    Filed: December 6, 2017
    Publication date: April 5, 2018
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Benjamin J. Feldman, Tianmei Ouyang, Zenghe Liu